Growth Metrics

Soleno Therapeutics (SLNO) Share-based Compensation (QoQ) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Soleno Therapeutics 2.76 Bn 2.51 Bn 93.41 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 39.97%
Dec 31, 2025 14.73%
Sep 30, 2025 3.09%
Jun 30, 2025 -33.93%
Mar 31, 2025 -50.67%
Dec 31, 2024 -47.43%
Sep 30, 2024 690.47%
Jun 30, 2024 11.09%
Mar 31, 2024 237.61%
Dec 31, 2023 -13.27%
Sep 30, 2023 82.81%
Jun 30, 2023 90.81%
Mar 31, 2023 -0.16%
Dec 31, 2022 -7.47%
Sep 30, 2022 19.61%
Jun 30, 2022 -11.34%
Mar 31, 2022 45.70%
Dec 31, 2021 -51.21%
Sep 30, 2021 5.72%
Jun 30, 2021 -21.74%
Mar 31, 2021 178.63%
Dec 31, 2020 5.08%
Sep 30, 2020 9.68%
Jun 30, 2020 -13.01%
Mar 31, 2020 92.16%
Dec 31, 2019 33.33%
Sep 30, 2019 -30.45%
Jun 30, 2019 -11.29%
Mar 31, 2019 -51.47%
Dec 31, 2018 121.21%
Sep 30, 2018 16.08%
Jun 30, 2018 -41.64%
Mar 31, 2018 135.17%
Dec 31, 2017 -35.84%
Sep 30, 2017 -48.98%
Jun 30, 2017 139.46%
Mar 31, 2017 -40.57%
Dec 31, 2016 51.10%
Sep 30, 2016 -5.50%
Jun 30, 2016 60.29%
Mar 31, 2016 -30.74%
Dec 31, 2015 36.37%
Sep 30, 2015 -28.36%
Jun 30, 2015 -49.88%
Mar 31, 2015 23.60%
Dec 31, 2014 6,388.70%
Sep 30, 2014 0.00%
Jun 30, 2014 -54.55%
Mar 31, 2014 221.92%